Company Filing History:
Years Active: 2023
Title: Alejandro Corvalán: Innovator in Non-Invasive Cancer Detection
Introduction
Alejandro Corvalán is a prominent inventor based in Santiago, Chile. He has made significant contributions to the field of medical diagnostics, particularly in the early detection of gastric cancer. His innovative approach focuses on non-invasive methods that can potentially save lives through early diagnosis.
Latest Patents
Corvalán holds a patent for a groundbreaking invention titled "Non-invasive detection of gastric cancer by detecting the methylation of Reprimo-like in the blood." This invention aims to provide a non-invasive method for the early diagnosis of gastric cancer by utilizing the levels of methylation of the DNA sequence of the promoter of the Reprimo-like gene found in plasma. The utility of Reprimo-like as a biomarker has been established, demonstrating its effectiveness in detecting gastric cancer at both incipient and advanced stages. The method allows for the measurement of methylation in plasma samples, facilitating a liquid biopsy that is non-invasive, fast, and cost-effective.
Career Highlights
Corvalán is affiliated with Pontificia Universidad Católica de Chile, where he continues to advance his research and innovations. His work has garnered attention for its potential impact on cancer diagnostics, making significant strides in the medical field.
Collaborations
One of his notable collaborators is Alejandra Alarcón, who has worked alongside him in developing and refining his innovative methods for cancer detection.
Conclusion
Alejandro Corvalán's contributions to the field of medical diagnostics, particularly through his patent on non-invasive gastric cancer detection, highlight the importance of innovation in healthcare. His work exemplifies how scientific advancements can lead to improved diagnostic methods that are accessible and efficient.